Preclinical and Phase I Results of Decitabine in Combination with Midostaurin (PKC412) for Newly Diagnosed Elderly or Relapsed/Refractory Adult Patients with Acute Myeloid Leukemia
出版年份 2013 全文链接
标题
Preclinical and Phase I Results of Decitabine in Combination with Midostaurin (PKC412) for Newly Diagnosed Elderly or Relapsed/Refractory Adult Patients with Acute Myeloid Leukemia
作者
关键词
-
出版物
PHARMACOTHERAPY
Volume 33, Issue 12, Pages 1341-1352
出版商
Wiley
发表日期
2013-06-24
DOI
10.1002/phar.1316
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- CBL mutation-related patterns of phosphorylation and sensitivity to tyrosine kinase inhibitors
- (2012) H Makishima et al. LEUKEMIA
- Targeting the FMS-like tyrosine kinase 3 in acute myeloid leukemia
- (2012) R Swords et al. LEUKEMIA
- Genome Wide Analysis of Acute Myeloid Leukemia Reveal Leukemia Specific Methylome and Subtype Specific Hypomethylation of Repeats
- (2012) Marwa H. Saied et al. PLoS One
- Clinical Applications of Epigenetic Markers and Epigenetic Profiling in Myeloid Malignancies
- (2012) Michael A. McDevitt SEMINARS IN ONCOLOGY
- p53-Independent, Normal Stem Cell Sparing Epigenetic Differentiation Therapy for Myeloid and Other Malignancies
- (2012) Yogen Saunthararajah et al. SEMINARS IN ONCOLOGY
- Phase 1 study of epigenetic priming with decitabine prior to standard induction chemotherapy for patients with AML
- (2011) J. M. Scandura et al. BLOOD
- Targeting levels or oligomerization of nucleophosmin 1 induces differentiation and loss of survival of human AML cells with mutant NPM1
- (2011) R. Balusu et al. BLOOD
- FLT3 ligand impedes the efficacy of FLT3 inhibitors in vitro and in vivo
- (2011) T. Sato et al. BLOOD
- FLT3/ITD AML and the law of unintended consequences
- (2011) M. Levis BLOOD
- Acute myeloid leukaemia in the elderly: a review
- (2011) Daniel A. Pollyea et al. BRITISH JOURNAL OF HAEMATOLOGY
- FLT3 inhibitors in the treatment of acute myeloid leukemia
- (2011) Naveen Pemmaraju et al. CANCER
- Molecular Genetics of Adult Acute Myeloid Leukemia: Prognostic and Therapeutic Implications
- (2011) Guido Marcucci et al. JOURNAL OF CLINICAL ONCOLOGY
- Mitoxantrone and etoposide with or without intermediate dose cytarabine for the treatment of primary induction failure or relapsed acute myeloid leukemia
- (2011) Steven M. Trifilio et al. LEUKEMIA RESEARCH
- FLT3 Inhibition as Therapy in Acute Myeloid Leukemia: A Record of Trials and Tribulations
- (2011) A. T. Fathi et al. ONCOLOGIST
- Novel Approaches to the Treatment of Acute Myeloid Leukemia
- (2011) G. J. Roboz Hematology-American Society of Hematology Education Program
- How I treat acute myeloid leukemia
- (2010) J. M. Rowe et al. BLOOD
- Intensive chemotherapy does not benefit most older patients (age 70 years or older) with acute myeloid leukemia
- (2010) H. Kantarjian et al. BLOOD
- Adult patients with acute myeloid leukemia who achieve complete remission after 1 or 2 cycles of induction have a similar prognosis
- (2010) Jacob M. Rowe et al. CANCER
- Activation of FOXO3a Is Sufficient to Reverse Mitogen-Activated Protein/Extracellular Signal-Regulated Kinase Kinase Inhibitor Chemoresistance in Human Cancer
- (2010) Jer-Yen Yang et al. CANCER RESEARCH
- Phase IIB Trial of Oral Midostaurin (PKC412), the FMS-Like Tyrosine Kinase 3 Receptor (FLT3) and Multi-Targeted Kinase Inhibitor, in Patients With Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome With Either Wild-Type or Mutated FLT3
- (2010) Thomas Fischer et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical response and miR-29b predictive significance in older AML patients treated with a 10-day schedule of decitabine
- (2010) W. Blum et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- FLT3-mutant allelic burden and clinical status are predictive of response to FLT3 inhibitors in AML
- (2009) K. W. Pratz et al. BLOOD
- Daunorubicin Versus Mitoxantrone Versus Idarubicin As Induction and Consolidation Chemotherapy for Adults With Acute Myeloid Leukemia: The EORTC and GIMEMA Groups Study AML-10
- (2009) Franco Mandelli et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Study of Clofarabine Monotherapy in Previously Untreated Older Adults With Acute Myeloid Leukemia and Unfavorable Prognostic Factors
- (2009) Hagop M. Kantarjian et al. JOURNAL OF CLINICAL ONCOLOGY
- Azacitidine Prolongs Overall Survival Compared With Conventional Care Regimens in Elderly Patients With Low Bone Marrow Blast Count Acute Myeloid Leukemia
- (2009) Pierre Fenaux et al. JOURNAL OF CLINICAL ONCOLOGY
- Multicenter, Phase II Study of Decitabine for the First-Line Treatment of Older Patients With Acute Myeloid Leukemia
- (2009) Amanda F. Cashen et al. JOURNAL OF CLINICAL ONCOLOGY
- Anthracycline Dose Intensification in Acute Myeloid Leukemia
- (2009) Hugo F. Fernandez et al. NEW ENGLAND JOURNAL OF MEDICINE
- BH3-only protein Bim more critical than Puma in tyrosine kinase inhibitor-induced apoptosis of human leukemic cells and transduced hematopoietic progenitors carrying oncogenic FLT3
- (2008) A. Nordigarden et al. BLOOD
- Age-Related Risk Profile and Chemotherapy Dose Response in Acute Myeloid Leukemia: A Study by the German Acute Myeloid Leukemia Cooperative Group
- (2008) Thomas Büchner et al. JOURNAL OF CLINICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now